Saltar al contenido

Elizabeth McKenna

@elizsmckenna.bsky.social did:plc:2jibvecxqio42sy5yc5667eu

Executive Editor of Cancer Discovery, published by AACR. Harvard BBS/Dana-Farber alum. Native New Yorker. Posts are my own. She/her https://aacrjournals.org/cancerdiscovery

En Bluesky desde el

Seguidores
4.173
Siguiendo
2.682
Posts
360
Días en rankings
0

Resumen

Elizabeth McKenna (@elizsmckenna.bsky.social) es un usuario de Bluesky que se unió el 11 septiembre 2023. Tiene 4.173 seguidores, sigue a 2.682 cuentas y ha publicado 360 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • AACR Journals@aacrjournals.bsky.social

    Stay tuned—nominations will open soon for our Early Career Awards: ➡️NEW! Blood Cancer Discovery Early Career Award ➡️Cancer Discovery Early Career Award ➡️Cancer Research Early Career Award ➡️Clinical Cancer Research Early Career Award

    Ver post
  • AACR Journals@aacrjournals.bsky.social

    Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/MPqGjG9

    Ver post
  • KenOliveLab@kenolivelab.bsky.social

    Congratulations to my dear friend Mallika Singh, who was just named as the new Head of Oncology at Abbvie! So well deserved after her extraordinary stewardship of the daraxonrasib development program at Revolution Medicines.

    Ver post
  • AACR Journals@aacrjournals.bsky.social

    Read the recent Cancer Discovery review article by #AACRpan26 Conference Cochair Eileen M. O’Reilly, “Pancreatic Cancer: Translating Tumor Biology into Actionability.” buff.ly/PCng7ti #OpenAccess

    Ver post
  • AACR Journals@aacrjournals.bsky.social

    Read the October issue of Cancer Discovery: buff.ly/vfDvoxr

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.